No Data
Bright Minds Initiated at Outperform by Baird, Longboard Takeover Cited
Hold Rating for Longboard Pharmaceuticals Amidst Acquisition Uncertainty and Speculative Risks
Express News | Longboard Pharmaceuticals Initiates Phase 3 Deep Ocean Study Evaluating Bexicaserin in Developmental and Epileptic Encephalopathies (Dees)
Longboard Pharmaceuticals Initiates Phase 3 DEEp OCEAN Study Evaluating Bexicaserin in Developmental and Epileptic Encephalopathies (DEEs)
Truist Financial Maintains Longboard Pharmaceuticals(LBPH.US) With Hold Rating
Longboard Pharmaceuticals Advances Neurological Treatments
101715680 : Give 20 days sure drop
10percents OP : why this is not moving up?